Document is current

Any future updates will be listed below

Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer

Crossref DOI link: https://doi.org/10.1007/s11523-014-0322-0

Published Online: 2014-05-27

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark